If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

SensiumVitals® expands distribution network

26 Mar 2014 07:00

RNS Number : 1876D
Toumaz Limited
26 March 2014
 



 

RNS REACH

26 March 2014

 

Toumaz Limited

SensiumVitals® expands international distribution network

Toumaz Limited (AIM: TMZ, 'Toumaz', or 'the Group'), a pioneer in ultra-low power wireless semiconductor technology, announces that Sensium Healthcare, its wireless healthcare division, has extended the sales reach of its SensiumVitals® vital signs monitor to 12 countries.

Sensium Healthcare has recruited its own highly experienced direct sales force in the UK, France and Germany. The company has also executed distribution agreements for another four territories in Scandinavia (Sweden, Norway and Denmark) and the Middle East (Bahrain).

Along with existing agreements in the USA, Canada, Mexico, Australia and New Zealand, SensiumVitals® now has distribution in countries which collectively account for 60% of global healthcare spend. The company has also received regulatory clearance for SensiumVitals® in Australia.

With this development of its sales and distribution networks, Sensium Healthcare is embarking on full commercialisation of the SensiumVitals® system. The company is currently in discussions with over 60 hospitals worldwide.

Anthony Sethill, CEO of Toumaz Group, said:

"In the last six months, we have established an experienced and highly effective international sales platform for SensiumVitals®.

Initial customer engagements have been very encouraging. SensiumVitals® is positioned as a "game changer" for patient safety and healthcare economics - and it is proving a compelling proposition with both clinicians and hospital managers.

In 2014, we expect a significant ramp up in Sensium Healthcare's revenues - as discussions already under way with hospitals in Europe, North America and Australia lead to deployments in all of those regions."

Enquiries:

Toumaz Limited

+44 (0)20 7391 0630

Anthony Sethill, Chief Executive Officer

Jonathan Apps, Chief Financial Officer

Instinctif Partners

+44 (0)20 7457 2056

Adrian Duffield/Rozi Morris/Kathy Gordon

About Toumaz (www.toumaz.com)

Toumaz Limited is a pioneer in low-power, wireless semiconductor and software technologies for healthcare and consumer audio. The Group has two divisions, Sensium Healthcare and Frontier Silicon. Sensium Healthcare develops wireless solutions for patient monitoring. Frontier Silicon provides chip, modules and software for digital radio and connected audio devices.

About SensiumVitals®

SensiumVitals® is an ultra-low power system for wireless monitoring of patient vital signs, including heart rate, temperature and respiration. Measurements are taken every two minutes, rather than every four to eight hours, as currently standard in general wards. Patient data is then sent wirelessly and securely to clinicians via hospital IT systems. 

The key benefit of SensiumVitals® is that it provides clinicians with rapid warnings of patient deterioration, which in turn allows for earlier interventions, shorter stays in hospital and lower healthcare costs. 

For more information, see http://www.sensium-healthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASEIFUIFLSEID
Date   Source Headline
26th Jun 20077:00 amPRNFinal Results
29th May 20077:00 amPRNProduct Collaboration
3rd May 20077:00 amPRNFuture Waves Design Win
20th Apr 20074:48 pmRNSHolding(s) in Company
23rd Mar 20075:04 pmRNSHolding(s) in Company
14th Mar 20074:36 pmRNSExercise of Options
26th Feb 20077:00 amPRNKey Development Milestone
21st Dec 200612:20 pmRNSResult of EGM
19th Dec 20067:02 amRNSToumaz Wins Oracle Award
5th Dec 20065:18 pmRNSNotice of EGM
22nd Nov 20065:41 pmRNSExercise of Options
3rd Nov 200611:55 amRNSExercise of Options
26th Oct 20064:09 pmRNSExercise of Options
13th Oct 20067:00 amPRNToumaz Debuts New Sensium(TM) Module
10th Oct 20063:58 pmRNSDirector/PDMR Shareholding
7th Sep 20065:12 pmPRNResult of AGM
7th Sep 20067:00 amPRNAppointment of CEO
6th Sep 20067:00 amPRNAGM Statement
23rd Aug 20067:00 amPRNStrategic Investment
18th Aug 20064:01 pmRNSHolding(s) in Company
3rd Jul 20067:00 amPRNDirectorate Change
30th Jun 20067:02 amRNSInterim Results
28th Apr 20067:00 amPRNFinal Results
21st Apr 20067:00 amPRNToumaz Appoints New CEO
13th Feb 200611:23 amRNSHolding(s) in Company
23rd Dec 20057:00 amPRNUpdate
11th Nov 20051:40 pmRNSHolding(s) in Company
9th Nov 20056:08 pmRNSHolding(s) in Company
7th Nov 200510:36 amRNSHolding(s) in Company
2nd Nov 20052:49 pmPRNResult of EGM
19th Oct 20051:35 pmRNSSchedule 1 - Nanoscience Inc
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
10th Oct 20056:00 amPRNAcquisition and Fundraising
21st Sep 20052:22 pmPRNInterim Results
31st Aug 200510:56 amPRNStrategic Investment
9th Jun 200510:00 amRNSRe Investment
3rd May 200512:17 pmRNSAppointment of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.